Human umbilical cord blood-mesenchymal stem cell derived exosomes as an efficient nanocarrier for Docetaxel and miR-125a: Formulation optimization and anti-metastatic behaviour

dc.contributor.authorChitkara, Deepak
dc.contributor.authorMittal, Anupama
dc.date.accessioned2024-01-05T10:49:14Z
dc.date.available2024-01-05T10:49:14Z
dc.date.issued2023-06
dc.description.abstractExosomes, as a nanocarrier for the co-delivery of biologicals and small anticancer molecules is yet in its infancy. Herein, we investigated hUCBMSC derived exosomes as a biogenic nanocarrier for the co-delivery of tumor suppressor miR-125a and microtubule destabilizing Docetaxel (DTX) to target the proliferative and migratory aggressiveness of the murine TNBC 4T1 cells.en_US
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0024320523002552
dc.identifier.urihttp://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13692
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.subjectPharmacyen_US
dc.subjectMSCen_US
dc.subjectExosomesen_US
dc.subjectDocetaxelen_US
dc.subjectMetastasisen_US
dc.subjectMulti-nucleationen_US
dc.titleHuman umbilical cord blood-mesenchymal stem cell derived exosomes as an efficient nanocarrier for Docetaxel and miR-125a: Formulation optimization and anti-metastatic behaviouren_US
dc.typeArticleen_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: